Come up with a name for your new list and we'll add to it:
InSphero raised a round of funding on March 27, 2012. Investors include
Swiss Commission of Technology and Innovation.
InSphero provides biological relevance to in vitro testing with its solutions for production, culture and assessment of more organotypic 3D cell culture models. The company's 3D cell culture platforms…